Compare PL & PTCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PL | PTCT |
|---|---|---|
| Founded | 2010 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Aerospace | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.3B | 5.5B |
| IPO Year | 2021 | 2006 |
| Metric | PL | PTCT |
|---|---|---|
| Price | $13.10 | $62.83 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 12 | 16 |
| Target Price | $30.27 | ★ $97.94 |
| AVG Volume (30 Days) | ★ 8.6M | 1.0M |
| Earning Date | 12-09-2026 | 10-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 264.48 |
| EPS | N/A | ★ 0.90 |
| Revenue | ★ $307,727,000.00 | $264,734,000.00 |
| Revenue This Year | $42.22 | N/A |
| Revenue Next Year | $30.36 | $9.47 |
| P/E Ratio | ★ N/A | $69.66 |
| Revenue Growth | 25.94 | ★ 36.19 |
| 52 Week Low | $10.52 | $58.80 |
| 52 Week High | $51.72 | $90.87 |
| Indicator | PL | PTCT |
|---|---|---|
| Relative Strength Index (RSI) | 29.66 | 46.72 |
| Support Level | N/A | $61.95 |
| Resistance Level | $18.49 | $72.86 |
| Average True Range (ATR) | 0.78 | 1.99 |
| MACD | -0.20 | 0.33 |
| Stochastic Oscillator | 2.44 | 61.44 |
Planet Labs PBC is an Earth-imaging company. It uses space to help life on Earth by imaging the world every day and making change visible, accessible, and actionable. Its platform includes imagery, insights, and machine learning that empower companies, governments, and communities around the world to make timely decisions about the evolving world. Its solutions are Broad Area Management. Its products are Planet Monitoring, Planet Tasking, Planet Analytic Feeds, Planetary Variables, Planet Basemaps, Planet Insights, and Platform Pricing. The group provides solutions to the Agriculture Science Program, Energy & Infrastructure, Forestry & Land Use, Mapping, Sustainability, Maritime, Civil Government, U.S. State and Local, Europe, Planet Federal, Defense & Intelligence, and Armed Services.
PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The company views its operations and manages its business in one operating segment: life science, which is focused on the discovery, development and commercialization of the company's clinically differentiated medicines that provide benefits to patients with rare disorders.